These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 10598691

  • 1. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367
    [Abstract] [Full Text] [Related]

  • 4. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R.
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [Abstract] [Full Text] [Related]

  • 7. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Dec; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/Timolol Study Group.
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [Abstract] [Full Text] [Related]

  • 10. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA, Polis A, Ostrov CS, Boyle JE.
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [Abstract] [Full Text] [Related]

  • 11. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T, Gross R, Pearson J, Rusk C, Adamsons I.
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1998 Oct; 105(10):1952-9. PubMed ID: 9787369
    [Abstract] [Full Text] [Related]

  • 13. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [Abstract] [Full Text] [Related]

  • 14. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M, Scoper SV, Arzeno G, James JE, Hua SY, Salem C, Dickerson JE, Landry TA, Bergamini MV, Brinzolamide 1%/Timolol 0.5% Study Group.
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [Abstract] [Full Text] [Related]

  • 15. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K, Snyder E, Adamsons I.
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [Abstract] [Full Text] [Related]

  • 17. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 18. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER, Vogel R, Tipping R, Clineschmidt CM.
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [Abstract] [Full Text] [Related]

  • 19. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C, Oksüz H.
    Ophthalmic Res; 2007 Aug; 39(1):24-31. PubMed ID: 17164574
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC.
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.